GLP-1 drugs , or glucagon-like peptide-1 analogs , represent a substantial shift in how we treat type 2 diabetes . These injectable drugs work by imitating the body’s natural GLP-1 process, which https://nimmansocial.com/story11815545/glp-1-a-significant-breakthrough-in-diabetes-care